CD4 and COVID-19: Preliminary studies indicate that COVID-19 vaccination is safe and immunogenic in people living with HIV that are virally suppressed on potent combination antiretroviral therapy (cART) but may be less immunogenic in HIV-infected individuals that have limited access to cART and whom have low CD4 counts (< 350 cell/mm3) or are immunosuppressed (3–6).